SCHEMBL21961908

SCHEMBL21961908

CC(O)(CCc1ccccc1)CC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 6/20 0.53
ADRA1A P35348 2/20 0.50
HMGCR P04035 1/20 0.50
CHRM1 P11229 1/20 0.50
TBXA2R P21731 1/20 0.50
CYP2C19 P33261 1/20 0.48
HIF1A Q16665 1/20 0.48
KEAP1 Q14145 1/20 0.48
POLB P06746 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
HDAC3 O15379 1/20 0.46
MAPK1 P28482 1/20 0.46
HDAC4 P56524 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20927213 0.84 ALDH1A1 (0.50) SLC13A5ADRA1AKEAP1MEN1KMT2A
SCHEMBL7450180 0.83 SLC13A5 (0.50) SLC13A5ADRA1ACYP2C19HIF1AKEAP1
SCHEMBL24137647 0.83 CA12 (0.46) SLC13A5POLBKDM4ELMNAHDAC3
SCHEMBL24137653 0.83 CA12 (0.46) SLC13A5POLBKDM4ELMNAHDAC3
SCHEMBL27820002 0.82 SLC13A5 (0.56) SLC13A5ADRA1AHMGCRCHRM1TBXA2R
SCHEMBL23080147 0.80 LMNA (0.50) CYP2C19MEN1KMT2ALMNAALDH1A1
Acetic Acid SCHEMBL15914114 0.80 ALDH1A1 (0.48) SLC13A5ADRA1AKEAP1POLBMEN1
SCHEMBL9419036 0.79 SLC13A5 (0.46) SLC13A5ADRA1ACYP2C19HIF1AKEAP1
SCHEMBL6632235 0.79 ALDH1A1 (0.50) SLC13A5ADRA1AHIF1AKEAP1POLB
SCHEMBL5475208 0.79 ALDH1A1 (0.50) SLC13A5ADRA1AHIF1AKEAP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210403445-A1 SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES CORNELL UNIVERSITY 2021-12-30 US disclosed
WO-2020102816-A1 SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES CORNELL UNIVERSITY (US) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403445-A1 SYSTEMS AND METHODS FOR REGIOSELECTIVE CARBONYLATION OF 2,2-DISUBSTITUTED EPOXIDES LTC4S, LSS, CYCS SLC13A5 3820/4885ADRA1A 2577/4885HMGCR 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.